Faculty

Tambi Jarmi, M.D.

Clinical Studies

Safety, tolerability and efficacy of AntiBKV as treatment of BKV infection in kidney transplant recipients, a randomized phase II/III study, double-blind and placebo controlled (SAFE KIDNEY II) Jacksonville, Fla., Scottsdale/Phoenix, Ariz.
The purpose of this study is to address an unmet need for a targeted treatment against BK polyomavirus (BKV) associated nephropathy (BKVAN) in kidney transplant recipients (KTRs).

Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured from Deceased Donors with High Kidney Donor Profile Index (KDPI) Jacksonville, Fla.
The purpose of this study is to assess the feasibility and safety of delivering adipose mesenchymal stem cells (AMSCs) to kidney allografts.
The use of Chimeric antigen receptor T cells (CAR-T) to treat highly sensitized patients on the kidney, heart or lung transplant waiting lists by depleting their B-cells Jacksonville, Fla.
The purpose of this study is to decrease the waiting time on the transplant list for patients who have high level of anti-HLA antibodies with ESRD and improve the patients and allograft survival after transplant.

Mayo Clinic Footer